Erratum: Review of the Patient Burden and Therapeutic Landscape of Irritable Bowel Syndrome with Constipation in the United States [Corrigendum] [0.03%]
便秘型肠易激综合征患者负担和美国治疗现状的评价及更正公告
[This corrects the article DOI: 10.2147/CEG.S464375.]. © 2024 Sendzischew Shane et al.
Published Erratum
Clinical and experimental gastroenterology. 2024 Nov 20:17:347-348. DOI:10.2147/CEG.S506887 2024
Therapeutic Potential of Etrasimod in the Management of Moderately-to-Severely Active Ulcerative Colitis: Evidence to Date [0.03%]
艾替洛尔治疗中至重度活动性溃疡性结肠炎的潜力：迄今为止的证据
Kerri Glassner,Christopher Fan,Malcolm Irani et al.
Kerri Glassner et al.
Etrasimod is a sphingosine 1 phosphate (S1P) receptor modulator approved for the treatment of moderate to severely active ulcerative colitis (UC). Etrasimod selectively activates S1P1,4,5 receptors with no detectable activity on S1P2,3. The...
Correlation Between Tumor Budding and Survivin Expression in Colorectal Cancer [0.03%]
肿瘤 budding与结直肠癌中Survivin表达的相关性分析
Guangping Zhang,Qingzhong Min
Guangping Zhang
Aim: Correlation of Survivin expression levels in tumor tissues and degree of tumor outgrowth with colorectal cancer characteristics. Methods: ...
Predicting Survival Among Colorectal Cancer Patients: Development and Validation of Polygenic Survival Score [0.03%]
结直肠癌患者的生存预测：多基因生存评分的开发与验证
Rawan M Maawadh,Chao Xu,Rizwan Ahmed et al.
Rawan M Maawadh et al.
Purpose: Colorectal cancer is the second leading cause of cancer-related death in the United States. A multi-omics approach has contributed in identifying various cancer-specific mutations, epigenetic alterations, and cel...
Refractory Crohn's Disease: Perspectives, Unmet Needs and Innovations [0.03%]
对顽固性克罗恩病的一些思考、未被满足的需求及创新观点
Luisa Bertin,Martina Crepaldi,Miriana Zanconato et al.
Luisa Bertin et al.
Crohn's disease (CD) is a complex, chronic inflammatory bowel disease characterized by unpredictable flare-ups and periods of remission. Despite advances in treatment, CD remains a significant health burden, leading to substantial direct he...
Patient-Generated Images in Perianal Disease: An Evolving Tool in Proctology [0.03%]
患者提供的肛周疾病图像：结直肠外科的一个新兴工具
Vipul D Yagnik,Kaushik Bhattacharya,Pankaj Garg et al.
Vipul D Yagnik et al.
This article explores the potential benefits and challenges of incorporating Patient-Generated Images (PGIs) into the clinical practice for perianal conditions. PGIs refer to photographs (and video) captured by patients themselves of affect...
Review of the Patient Burden and Therapeutic Landscape of Irritable Bowel Syndrome with Constipation in the United States [0.03%]
美国便秘型肠易激综合征患者的疾病负担及治疗现状评述
Morgan Allyn Sendzischew Shane,Johannah Ruddy,Michael Cline et al.
Morgan Allyn Sendzischew Shane et al.
Irritable bowel syndrome (IBS) is a common disorder of the gut-brain axis. IBS with constipation (IBS-C) accounts for approximately one-third of IBS cases and is associated with substantial burden of illness and decreased quality of life. T...
Real-World Situation of Eradication Regimens and Risk Factors for Helicobacter pylori Treatment in China: A Retrospective Single-Center Study [0.03%]
中国根除幽门螺杆菌方案应用现状及影响治疗效果的风险因素：一项基于单中心的回顾性研究
Jianping Cheng,Chanjuan Fan,Zhen Li et al.
Jianping Cheng et al.
Background and objectives: The success rate of Helicobacter pylori (H. pylori) eradication in China is declining. The aim of this study was to evaluate eradication outcomes in clinical practice and identifies factors cont...
Validating the CHAMPS Score: A Novel and Reliable Prognostic Score of Non-Variceal Upper Gastrointestinal Bleeding [0.03%]
验证CHAMPS评分：非静脉曲张性上消化道出血新型且可靠的预后评分
Huong Tu Lam,Thang Dinh Nguyen,Hoang Huu Bui et al.
Huong Tu Lam et al.
Introduction: The Charlson Comorbidity Index ≥2, in-Hospital onset, Albumin 65 years (AIMS65) score (AUROC = 0.72 and 0.71, respectively; all p < 0.05). Subgroup analysis for bleeding-related and non-bleeding-related mor...
Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Cancer [0.03%]
立体放射治疗对局部晚期胰腺癌的有效性和安全性研究
Shane S Neibart,Shalini Moningi,Krishan R Jethwa
Shane S Neibart
Introduction: For patients with locally advanced pancreatic cancer (LAPC), who are candidates for radiation therapy, dose-escalated radiation therapy (RT) offers unique benefits over traditional radiation techniques. In t...